fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with bq 485 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akhteruzzaman, S; Hisaka, A; Kato, Y; Sugiyama, Y | 1 |
Akhteruzzaman, S; Hisaka, A; Kato, Y; Kouzuki, H; Meier, PJ; Stieger, B; Sugiyama, Y; Suzuki, H | 1 |
2 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and bq 485
Article | Year |
---|---|
Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane.
Topics: Adenosine Triphosphate; Animals; Anion Transport Proteins; Azepines; Bile Canaliculi; Biological Transport, Active; Carrier Proteins; Drug Interactions; Endothelin Receptor Antagonists; Ethers; Hydrocarbons, Fluorinated; Hyperbilirubinemia; Kinetics; Liver; Male; Membranes; Oligopeptides; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Tritium | 1999 |
Carrier-mediated hepatic uptake of peptidic endothelin antagonists in rats.
Topics: Anesthetics, Inhalation; Animals; Antihypertensive Agents; Azepines; Binding, Competitive; Biological Transport, Active; Carrier Proteins; Cells, Cultured; COS Cells; Endothelin Receptor Antagonists; Ethers; Hydrocarbons, Fluorinated; Kinetics; Liver; Male; Oligopeptides; Peptides; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Transfection | 1999 |